Illumina, Inc.
ILMN
Jodie situation report
Illumina, Inc.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 22 directly disclosed connections are confirming.
- ILMN's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if ILMN's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind ILMN
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
LABFiling-linked nameinvesteeFeb 12, 2026 ▾
“SUBSEQUENT EVENTS On January 30, 2026, we acquired SomaLogic and other specified assets from Standard BioTools for a $ 350 million upfront cash payment, subject to customary adjustments.”
Depended on by
CDNACareDx, Inc.supplierApr 28, 2026 ▾
“These sole source suppliers include Thermo Fisher Scientific, Inc., or Thermo Fisher, which supplies us with instruments, laboratory reagents and consumables; Roche Molecular Systems, which supplies us with laboratory reagents and consumables; Hamilton Roboti…”
Filing peers
No filing peers are available for this name yet.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 20 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
ILMN is currently a Leader in the organic co-movement group Genomic Sequencing. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for ILMN; it is not active in the latest market snapshot.